Position in SANA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,598,251
+$1,339,163 QoQ
Shares Held
1,604,084
+8.5% QoQ
Ownership
0.536%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. SANA ranks #154 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,598,251 | 1,604,084 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $4,259,088 | 1,478,851 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,729,332 | 1,407,699 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $4,680,658 | 1,318,496 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,151,275 | 1,154,314 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,182,860 | 1,299,323 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,937,003 | 1,188,346 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,693,900 | 1,128,342 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $4,665,962 | 854,572 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $8,661,410 | 866,141 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,618,848 | 886,973 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,222,187 | 832,607 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,861,564 | 815,699 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,493,046 | 762,400 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,083,550 | 780,646 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,743,090 | 790,515 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,103,328 | 793,675 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,263,522 | 758,296 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,294,013 | 794,187 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $17,703,376 | 786,118 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,727,526 | 291,329 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,495,136 | 164,181 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||